학술논문

In‐hospital outcomes of transcatheter mitral valve repair in patients with and without end stage renal disease: A national propensity match study
Document Type
article
Source
Catheterization and Cardiovascular Interventions. 98(2)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Transplantation
Clinical Research
Health Services
Kidney Disease
Renal and urogenital
Good Health and Well Being
Cardiac Catheterization
Heart Valve Prosthesis Implantation
Hospitals
Humans
Kidney Failure
Chronic
Mitral Valve
Mitral Valve Insufficiency
Treatment Outcome
end-stage renal disease
percutaneous edge-to-edge mitral valve repair
percutaneous mitral valve repair with clip
Cardiorespiratory Medicine and Haematology
Cardiovascular System & Hematology
Cardiovascular medicine and haematology
Language
Abstract
ObjectivesTo study trends of utilization, outcomes, and cost of care in patients undergoing undergoing transcatheter mitral valve repair (TMVr) with end-stage renal disease (ESRD).BackgroundRenal disease has been known to be a predictor of poor outcome in patients with mitral valve disease. Outcome data for patients with ESRD undergoing TMVr remains limited. Therefore, our study aims to investigate trends of utilization, outcomes, and cost of care among patients with ESRD undergoing TMVr.MethodsWe analyzed NIS data from January 2010 to December 2017 using the ICD-9-CM codes ICD-10-CM to identify patients who underwent TMVr. Baseline characteristics were compared using a Pearson ?2 test for categorical variables and independent samples t-test for continuous variables. Propensity matched analysis was done for adjusted analysis to compare outcomes between TMVr with and without ESRD. Markov chain Monte Carlo was used to account for missing values.ResultsA total of 15,260 patients (weighted sample) undergoing TMVr were identified between 2010 and 2017. Of these, 638 patients had ESRD compared to 14,631 patients who did not have ESRD. Adjusted in-hospital mortality was lower in non-ESRD group (3.9 vs.